Updated April 2021 8%. That is the five-year survival rate for someone diagnosed with pancreatic cancer in Canada. This disease waits for no one, so neither do we – even amidst a global pandemic. For over 40 years there has been a “one size fits...
Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
What you Need to Know About Wills in 40 Minutes On Demand Webinar With so much to consider, we know creating or updating your will can be a daunting task. That’s why we asked Certified Executor Advisor Walter Viner to share some important advice with our...
OUR IMPACT: 2019 OUR IMPACT: 2019 A Year In Review 2019 was a year of growth, inspiration and tenacity. We set out to make significant research and awareness investments, grow our support programs, and further our partnerships to deliver services and...
Community fundraiser adapts amidst global pandemic By Ali Schofield Dedicated. Resilient. Compassionate. These are just a few words that describe Pam Kosolofski, a steadfast champion of progress for pancreatic cancer patients – even amidst a global pandemic. Each...
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada’s research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of...
Recent Comments